OmniAb
Emeryville, California, BI · Biotechnology, research · 120 employees
The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.
Funding history
- Venture - Series Unknown · $30.0M · Sep 2025
Recent signals
- Aug 17, 2026: OmniAb and Eli Lilly Forge Global Collaboration and License Agreement for Ion Channel Program
- Jul 13, 2026: OmniAb Appoints Amechi Nwachuku as Chief Operating Officer
- Sep 10, 2025: Raised $30.0M in Venture - Series Unknown
See plans & pricing → Track OmniAb’s funding, hiring and signals, with verified contacts, on Fundz.
Fundz watches OmniAb across 18 signal types, from funding and M&A to exec moves and hiring.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.